drugset / Trial / NCT01909999

Release of Osteogenic Markers in Immediately and Non-loaded Dental Implants

NCT01909999

Completed 40 enrolled Renato Correa Viana Casarin
RandomizedParallel-groupOpen-labelScreening

Summary

The aim of this study was to compare the release of the osteoprotegerin (OPG), transforming growth factors (TGF-α), osteocalcin (OCN), osteopontin (OPN), and parathyroid hormone (PTH) during osseointegration of dental implants with and without immediate loading. Forty patients were selected and randomly divided into: Group IM - implant and prosthesis placement within 72 hours; and Group NL - implant insertion and no prosthesis placement during 120 days. Peri-implant crevicular fluid (PICF) was collected immediately after implant insertion and with 7, 15, 30, 60, 90, and 120 days after surgery and were evaluated levels of OPG, TGF-α, OCN, OPN and PTH using Luminex assay. Clinical aspects (Sulcus bleeding and peri-implant probing depth) were also assessed. The data were compared using the ANOVA/Tukey and Friedman/Mann-Whitney tests (α=5%).

Timeline

Start
2010-03
Primary completion
2012-10
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Background Amoxicillin Other / unclassified 500 mg
Background Chlorhexidine Small molecule 0.12 %
Background sodic dipyrone Unknown 500 mg